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Abstract
Mycobacterium immunogenum is an emerging pathogen of the immune-mediated lung disease hypersensitivity
pneumonitis (HP) reported in machinists occupationally exposed to contaminated metal working fluid (MWF). However,
the mechanism of its interaction with the host lung is unclear. Considering that alveolar macrophages play a central role in
host defense in the exposed lung, understanding their interaction with the pathogen could provide initial insights into the
underlying immunopathogenesis events and mechanisms. In the current study, M. immunogenum 700506, a predominant
genotype isolated from HP-linked fluids, was shown to multiply intracellularly, induce proinflammatory mediators (TNF-a, IL-
1a, IL-1b, IL-6, GM-CSF, NO) and cause cytotoxicity/cell death in the cultured murine alveolar macrophage cell line MH-S in a
dose- and time-dependent manner. The responses were detected as early as 3h post-infection. Comparison of this and four
additional genotypes of M. immunogenum (MJY-3, MJY-4, MJY-12, MJY-14) using an effective dose-time combination
(100 MOI for 24h) showed these macrophage responses in the following order (albeit with some variations for individual
response indicators). Inflammatory: MJY-3 $ 700506 . MJY-4 $ MJY-14 $ MJY-12; Cytotoxic: 700506 $ MJY-3 . MJY-4 $
MJY-12 $ MJY-14. In general, 700506 and MJY-3 showed a more aggressive response than other genotypes. Chemical
blocking of either p38 or JNK inhibited the induction of proinflammatory mediators (cytokines, NO) by 700506. However,
the cellular responses showed a somewhat opposite effect. This is the first report on M. immunogenum interactions with
alveolar macrophages and on the identification of JNK- and p38- mediated signaling and its role in mediating the
proinflammatory responses during these interactions.
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Introduction
Hypersensitivity pneumonitis (HP), an immunologically medi-
ated alveolar and interstitial lung pathology, is an occupational
disease that has been reported among machinists for more than a
decade [1]. HP-associated metal working fluids (MWF) used in
automotive plants and other machining operations have revealed
predominant growth of non-tuberculous mycobacteria (NTM) of
the M. chelonae-M. abscessus complex. These mycobacterial species
have been implicated in HP [2,3], among other respiratory
symptoms in the exposed machinists. Particularly, Mycobacterium
immunogenum (MI), a recently discovered member of this species
complex, has been linked with occupational HP in workers
exposed to contaminated MWF (from which this species has
frequently been cultured [4,5]). Subsequently, multiple genotypes
of M. immunogenum have been isolated from diverse MWF
operations in our recent efforts [6,7]. While M. immunogenum is
considered as the etiological agent of the MWF-associated HP
based on human epidemiological [8,9,10] and animal exposure
studies [11,12], the exact mode of interaction of this pathogen with
the exposed lung remains unclear. Also, the relative pathogenesis
potential of individual genotypes of this pathogen prevalent in the
occupational settings is not known.
In general, the outcome of lung exposure to respiratory bacterial
pathogens is believed to be the net consequence of the innate and
adaptive immune defenses of the host and a pathogen’s capacity to
subvert them. It is well known that alveolar macrophages play a
central role in regulating the innate and acquired immune
responses against pathogens. Moreover, alveolar macrophages
are largely considered to be the preferential site for bacterial killing
or proliferation thereby generating the antigen load of the
pathogen in human lung tissue [13]. Mycobacteria, in general,
activate both humoral and cell-mediated immune responses in
other infections [14,15]. However, the mechanism(s) by which M.
immunogenum interaction occurs in the lung destined for HP
development is not yet clear. Given that HP is a cell-mediated
immune disorder, it may be assumed that innate activation of
macrophages and development of cell-mediated immunity is
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critical in this disease process. The regulation of key cytokines by
alveolar macrophages is considered one of the important immune
regulatory functions during development of T-helper cell pheno-
types. However, the pattern of expression of these mediators in M.
immunogenum interactions with alveolar macrophages has not yet
been reported. Hence, understanding the alveolar macrophage
response to M. immunogenum infection will pave the way for
understanding the pathogenesis mechanisms of mycobacterial HP.
In host-pathogen interaction, different strains or variants
(genotypes or morphotypes) of a pathogen might show differential
pathogenesis by responding differently in terms of intracellular
survival/growth and induction of host response. Understanding
these differences may allow understanding of the basis of virulence
potential of individual strains and the responsible virulence factors.
Since practically nothing is known about the relative virulence/
immunogenic potential of M. immunogenum strains/variants, we
compared five M. immunogenum genotypes, originally isolated in our
previous efforts, for their interaction with alveolar macrophages.
Considering that no information is available on the signaling
mechanisms underlying the lung inflammatory response in HP, it
is significant that this study demonstrates contribution of MAP
kinase-mediated signaling in alveolar macrophage activation and
response caused by M. immunogenum. To our knowledge, this marks
the beginning of understanding of the signaling mechanisms of
host-pathogen interaction in this emerging pathogen.
Materials and Methods
Strains and culture conditions
Mycobacterium immunogenum genotypes 700506, MJY-3 MJY-4,
MJY-12 and MJY-14, originally isolated from diverse contami-
nated metal working fluids [7,5] were maintained by sub culturing
on Middlebrook 7H10 agar or in Middlebrook 7H9 broth (Difco
Laboratories, Sparks, MD, USA) and storing as frozen glycerol
stocks in the same medium. Each genotype was grown to mid-log
phase in Middlebrook 7H9 broth (Difco Laboratories, Sparks,
MD, USA) supplemented with 10% Oleic acid-Albumin-Dex-
trose-Catalase (OADC) enrichment medium (BD Biosciences,
Sparks, MD, USA) and 0.5% glycerol with continuous shaking
(150 rpm) at 37uC to a 150 Klett reading (equivalent to
approximately 109 cfu/ml) measured by using a Klett photoelec-
tric colorimeter (Klett, New York, NY, USA). Shaking reduced the
cell clumping thereby facilitating the subsequent procedure for
generation of a monodispersed cell suspension (see details below).
Alveolar macrophages
Murine alveolar macrophage cell line MH-S (CRL-2019),
purchased from the American Type Culture Collection (ATCC),
Manassas, VA, USA, and was used. The MH-S cells were
maintained in RPMI 1640 medium (ATCC, Manassas, VA, USA)
supplemented with 10% fetal bovine serum and 1% streptomycin-
penicillin-glutamate solution (Invitrogen, Carlsbad, CA, USA).
Cells were grown for 48h at 37uC in a humidified 5% CO2
incubator, and were collected, counted, and adjusted to a
concentration of 16106 cells/ml for further use. The alveolar
macrophage cells were seeded in 12-well culture clusters at a
density of 16106 cells/well 12 hours prior to the bacterial
challenge.
Preparation of single-cell suspensions of M. immuno-
genum genotypes for infection For all macrophage infection
experiments with M. immunogenum 700506, single cell suspension
for use as inoculum was prepared as follows. A liquid culture
(50 ml) grown to mid-log phase (150 Klett reading) was
centrifuged at 3000 x g for 15 min and the cell pellet resuspended
in 10 ml of complete RPMI medium (without antibiotics). The
suspension was passed serially (ten times) through a 20 gauze
syringe needle using a glass syringe and then through a 25 gauze
syringe needle. Remaining small clumps were removed with
additional centrifugation at 3506g for 5 min. The resulting single
cell suspension, confirmed based on microscopy, was quantified
(colony forming units/ml) by spread plate method using Mid-
dlebrook 7H10 agar (supplemented with OADC). A freshly
prepared inoculum prepared using this optimized protocol was
used for macrophage infections. For genotype comparison
experiments, individual genotypes were first grown on 7H10
agar-OADC plates and 10 loopfuls of bacterial cells from each
plate were separately resuspended in 10 ml of complete RPMI
medium and single cell suspensions were prepared by serial
passaging through syringe needles as described above. All inocula
were normalized to 108 cfu/ml before use in infection experi-
ments.
Experimental design
M. immunogenum genotype 700506 was used as a reference strain
to investigate the effective dose- and time- of exposure. The
selected dose-time combination was then used for comparing the
different genotypes. The freshly propagated MH-S cells, first
allowed to adhere as monolayers in 12-well culture clusters (16106
cells/well), were infected with the 700506 inoculum at varying
multiplicity of infection (MOI), ranging from .001 (103 cfu/106
MH-S cells) to 1000 (109 cfu/106 MH-S cells) MOI. MH-S cells
stimulated with lipopolysaccharide (LPS, Sigma Aldrich, St. Louis,
MO) @ 500 ng/ml served as positive control for assay validations.
Figure 1. Induction of cellular responses (in terms of LDH
release and cell death) in the MH-S cells after 24h exposure to
M. immunogenum 700506. A. Effect of varying the infection dose. B.
Effect of time course after exposure to a selected infection dose (100
MOI). Values presented as means 6 standard deviations are from three
independent experiments; each experiment was done in triplicate.
Asterisk (*) indicates statistically significant (P#0.05) difference as
compared to the vehicle control.
doi:10.1371/journal.pone.0083172.g001
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The MH-S cells treated with an equal volume of the vehicle
(antibiotic-free RPMI medium) were used as negative control.
Each treatment was carried out in triplicate. Subsequently, the
experimental 12-well cultures challenged with the selected effective
infection dose were incubated at 37uC in a humidified 5% CO2
incubator for varying periods of time (3h, 6h, 12h and 24h). At
each time point, the treated cells were harvested and subjected to
further analyses. The selected effective pathogen dose and time
combination was then used to compare the other four genotypes
(MJY-3, MJY-4, MJY-12 and MJY-14).
In an independent experiment, the MH-S cells were treated
with MAP kinase inhibitors, using two different doses (20 mM and
40 mM) of the p38 inhibitor SB202190 (EMD Biosciences, San
Diego, CA), or the JNK inhibitor SP600125 (EMD Biosciences,
San Diego, CA), 1h prior to the challenge with M. immunogenum
700506. Positive (no-inhibitor) and negative (vehicle) controls were
run in parallel for comparison. Macrophage cells were harvested
at 24h post-exposure and subjected to further analysis, as
described below.
Cytotoxicity
Cytotoxicity in the pathogen-challenged MH-S cells was
measured in terms of release of lactate dehydrogenase (LDH)
using Cyto Tox96 non-radioactive cytotoxicity assay kit (Promega,
Madison, WI, USA) per manufacturer’s instructions.
Cell viability
Macrophage cell viability changes were estimated using trypan
blue staining (Invitrogen, Carlsbad, CA, USA) for microscopic
counting of the live and dead cells using hemocytometer (Bausch &
Lomb Rochester, NY USA).
Nitric oxide (NO)
The levels of NO in the culture supernatants were estimated as
nitrite using the Griess reagent system per manufacturers’
instructions (Promega, Madison, WI, USA).
Measurement of cytokines by ELISA
Levels of different cytokines (TNF-a, IL-6, 1L-1a, IL-1b, and
IL-10 and GM-CSF) were measured in the culture supernatants or
cell lysates from macrophage monolayers infected with M.
immunogenum genotypes. Sandwich ELISA kits were used to detect
Figure 2. Determination of intracellular replication of M. immunogenum 700506 in alveolar macrophages (MH-S cells). A. Cells
infected with bacteria for 1 hour were made free of extracellular bacteria by repeated (3x) washing followed by gentamycin treatment as described
under Materials and Methods section and their intracellular bacterial load was monitored for 72 hours based on CFU analysis. B. Inactivation of
extracellular bacteria in gentamycin treatment. Log CFU values presented as means 6 standard deviations are from three independent experiments;
each experiment was done in triplicate. Asterisk (**) indicates statistically significant (P#0.01) difference as compared to the values for other time
points. C& D. Transmission electron microscopy (TEM) images of uninfected (C) and MI-infected (D) cells at a magnification of 30000X. Black arrows
indicate the intracellular M. immunogenum cells. Abbreviations: Gm (gentamycin), Mi (M. immunogenum), Nuc (nucleus), Vac (vacuole), and Mito
(mitochondrion), respectively.
doi:10.1371/journal.pone.0083172.g002
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the cytokine levels, following the manufacturer’s protocol and
instructions (eBioscience, San Diego, CA, USA).
Determination of intracellular pathogen replication
MH-S cells (16106 cells/well) were adhered for 4 hours
followed by washing (three times) with RPMI medium-without-
antibiotics (RPMI-A). The cells were infected with MI 700506 at
10 multiplicity of infection (MOI) for 1hour, followed by washing
(3x) with RPMI-A medium and incubation in presence of
gentamycin (10 mg/ml) for 30 min. to kill extracellular bacteria
in the medium. The infected cells were again washed (3x) followed
by incubation in RPMI-A medium. Efficacy of the gentamycin
treatment in terms of complete inactivation of the extracellular
bacteria was confirmed by plating the culture supernatant on
Sauton’s agar. For determination of intracellular pathogen load,
the cells were lysed at different time points of incubation, using
SDS (0.25%) and neutralized using bovine albumin (0.1%). Serial
dilutions of the lysate were spread plated on Sauton’s agar for
determination of the intracellular pathogen load in terms of colony
forming units (CFUs).
Transmission electron microscopy
MI 700506-infected (24 hours) and uninfected (control) MH-S
cells were washed twice in 0.175 M sodium cacodylate buffer
(pH 7.4) and fixed using 3% gluteraldehyde. The fixed cells were
processed for transmission electron microscopy at the Cincinnati
Children’s Hospital Medical Center Pathology Research Core
facility, using their standard procedures. Images were taken at a
magnification of 30,000 X using AMT digital camera system
(Advanced Microscopy Techniques, Corp., Woburn, MA, USA).
Western blot analysis
MH-S cells (16106/well) adhered for 4 hours in a 12-well plate
were infected with MI 700506 for 60 min. using various MOIs,
ranging from 0.001 to 1000. The infected cells were washed (3x)
with RPMI-A and lysed with RIPA buffer containing a protease
and phosphatase inhibitors cocktail. Western blot analysis was
performed using the primary antibodies anti-phospho p38, anti-
p38, anti-phospho SAPK/JNK, and anti-SAPK/JNK (all from
Cell Signaling Technology, Boston, MA, USA), each at a dilution
of 1:1000. Anti-b Actin was used at a dilution of 1:10,000 (Sigma,
USA). HRP-conjugated anti-rabbit and anti-mouse secondary
antibodies (Cell Signaling Technology, Boston, MA, USA) were
used at 1:1000 and 1:2000 dilutions, respectively. The bands were
visualized with an ECL kit per manufacturer’s instructions (Pierce
Chemical, Rockford, IL, USA) and subjected to densitometric
quantification using the NIH Image J software.
Statistical analysis
The data are presented as means 6 standard deviation (SD)
obtained from at least three independent experiments, each
performed in triplicate. Differences between groups were assessed
by the paired two-tailed Student’s t test with level of significance
P#0.05 (n = 9) being accepted as statistically significant.
Results
1. Dose- and time- dependent responses of alveolar
macrophages to MI exposure
Alveolar macrophages infected with MI 700506 showed dose-
and time-dependent immunological and cellular responses.
Macrophage cytotoxicity and cell death. LDH release, an
indirect indicator of cytotoxicity, due to the loss of cell membrane
integrity or cell lysis, increased in a dose- and time- dependent
manner in the MH-S cells infected with MI 700506. The LDH
release (Fig 1A) began at 0.001 MOI and continued to show a
steady increase with dose through 100 MOI. This was followed by
a more dramatic increase in the next higher dose (1000 MOI). The
more direct assay for viability loss (Trypan blue exclusion-based
assay) yielded a dose-response pattern quite parallel to the one
followed by the LDH release (Fig 1A). Time-course exposure (3h
to 24h) of the MH-S cells with 100 MOI (a dose that gave a
reasonably high measurable response) showed a significant
induction of cytotoxicity as early as 3h which continued through
24h post-infection (Fig 1B). In terms of cell viability, the selected
dose caused a slight loss at 3h post-infection but a significant loss
after 6h of infection, which continued to increase through 24h
post-infection (Fig 1B). This showed that onset of LDH increase
preceded the onset of viability loss in the infected macrophages.
Intracellular replication of the pathogen. The fate of M.
immunogenum inside the macrophages is not known. To examine
whether MI survives and replicates inside the alveolar macro-
phages post-phagocytosis (1 hour), we followed infection dynamics
for 72 hours. The test strain showed a steady increase in
intracellular multiplication leading to a 2.6 log increase in
pathogen load (Fig 2A). The measured bacterial load was a result
of the replicating intracellular bacteria, as gentamycin was shown
to completely inactivate all extracellular bacteria (Fig 2B). Direct
evidence for the intracellular presence of MI was obtained by
Transmission electron microscopy on 24h-infected cells wherein
MI was seen localized mostly in vacuoles (Fig 2C and D). We also
Figure 3. Induction of nitric oxide (NO) production (measured
as nitrite) in MH-S cells after 24h exposure to M. immunogenum
700506. A. Effect of varying the infection dose. B. Time course of NO
production after exposure to a selected dose (100 MOI). Values are
presented as means 6 standard deviations calculated based on the
data obtained from three independent experiments; each experiment
was done in triplicate. Asterisk (*) indicates statistically significant
(P#0.05) difference as compared to the vehicle control.
doi:10.1371/journal.pone.0083172.g003
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Figure 4. Induction of cytokine response in MH-S cells after 24h post-exposure to M. immunogenum 700506. A. Effect of varying the
infection dose on the expression of different cytokines in MH-S cells at 24h post-infection (a) IL-1a (b) IL-1b, (c) TNF-a, (d) IL-6, (e) GM-CSF. B. Time
course of expression of different cytokines in MH-S cells exposed to an infection dose of 100 MOI (a) IL-1a (b) IL-1b, (c) TNF-a, (d) IL-6, (e) GM-CSF.
Values are presented as means 6 standard deviations calculated based on the data obtained from three independent experiments; each experiment
was done in triplicate. A statistically significant (P#0.05) value as compared to vehicle control is indicated by an asterisk (*).
doi:10.1371/journal.pone.0083172.g004
M. immunogenum Interaction with Macrophages
PLOS ONE | www.plosone.org 5 December 2013 | Volume 8 | Issue 12 | e83172
observed indication of the presence of intracellular bacteria in the
macrophage cells by acid fast staining method (data not shown).
NO Production. Extracellular NO production increased in a
dose- and time- dependent manner compared to the vehicle
control (3.4260.104 mM). In the dose-response experiment (Fig
3A), there was a significant (p#0.05) increase in NO production at
doses 0.1 MOI (6.0460.105 mM) through 1000 MOI
(12.7861.25 mM). The increase was more pronounced and
comparable at the high doses (100 and 1000 MOI). In the time-
course analysis (Fig 3B), the 100 MOI dose resulted in a significant
increase in NO induction beginning at the 12h time-point and
continuing through 24h post-infection. Unlike cytotoxicity/cell
vitality loss, no significant induction was observed at 3h and 6h
post-infection, as compared to the vehicle control.
Expression of cytokines. The proinflammatory cytokines
TNFa, IL-1b, IL-1a, and IL-6 and GM-CSF were found to be
upregulated in a dose- and time- dependent manner whereas the
anti-inflammatory cytokine IL-10 was not detected within or
outside the cells in the infected macrophage cultures (Fig 4).
Similar to the cellular responses, all upregulated proinflammatory
cytokines showed an increase in expression with the increase in
pathogen dose and the effect was significant at 100 and 1000 MOI
(Fig 4A subpanels a through e). In terms of the production kinetics,
majority of the inflammatory cytokines were detected as early as
3h post-infection and increased gradually with time reaching a
maximum at the highest time point (24h) post-infection (Fig 4B-
subpanels a through e). Interestingly, IL-1b and IL-1a were
detected primarily in cell lysates, indicating their intracellular
localization (Fig 4B- subpanels a and b). Significant induction
(p#0.0012) in IL-1a production was also detected extracellularly
but only at 24h post-infection at the highest doses (100 and 1000
MOI).
2. Comparison of MI genotypes for macrophage
response
The preceding MI 700506 experiments allowed us to select an
effective and realistic dose-time combination (100 MOI for 24h)
based on induction of cellular and immunological responses in
MHS cells. Using this dose (100 MOI) and exposure time (24h)
combination, both inflammatory and cellular damage responses
were compared for the five different MI genotypes, namely
700506, MJY-3, MJY-4, MYJ-12 and MJY-14.
Of these, the 700506 genotype gave the highest cellular
response. MJY-3 increased LDH release (up to 53.465.66%) to
significantly (p#0.0057) higher levels as compared to the other
genotypes next only to the 700506 genotype (74.8613.4%). This
cytotoxicity trend paralleled with the observed cell viability loss in
the MJY-3 treated group (42.7612.84 percent) as compared to
700506 (53.63610.30%) and other genotypes (Fig 5). These results
demonstrate that MJY-3 is the most potent among the other four
genotypes in terms of inducing a cellular response in alveolar
macrophages.
The individual genotypes showed significant but differential
response in terms of induction of proinflammatory mediators
(cytokines/NO) in the MH-S cells (Fig 6 A-F). In terms of cytokine
expression, MJY-3, MJY-4, and MJY-14 showed relatively higher
responses than 700506 whereas MJY-12 showed the lowest
response. For NO induction, MJY-3 induced the highest amount
of NO (6.460.5 mM), next only to 700506, as compared to the
other genotypes (MJY-14, MJY-4, and MJY-12). Collectively, the
results imply that MJY-3 and 700506 are the most potent
genotypes for inducing inflammatory and cellular damage
responses in alveolar macrophages.
3. Role of MAPK signaling in macrophage response to M.
immunogenum
Considering the highest potential of MI 700506 for induction of
cellular and immunological responses in MH-S cells, we chose this
genotype to examine the role of MAPK pathway signaling in
cytotoxicity/cell death and inflammatory response (cytokine/NO
expression). Infection of MH-S cells with increasing pathogen dose
(0.001 through 1000 MOI) for 1 hour upregulated the total p38
and JNK levels and efficiently phosphoactivated JNK and p38 in a
dose-dependent manner, as evident from the immunoblots
obtained using total- and phospho- p38 (Thr180/Tyr182) and
total- and phospho-JNK( Thr183/Tyr185) specific antibodies (Fig
7A and B). Unlike JNK expression levels which were upregulated
significantly at all infection doses, p38 levels required a minimum
infection dose of 0.1 MOI for its upregulation. The dose-response
for JNK upregulation however showed a non-linear trend unlike
p38 which showed an almost linear dose-dependent trend (Fig 7A).
The phosphoactivation did not follow the same trend as the
upregulation (Fig 7B). For instance, p38 was phosphoactivated at
all doses whereas JNK was activated beginning 0.01 MOI. A
noticeable difference in p38 and JNK was the differential effect of
the highest infection dose (1000 MOI); while p38 showed almost
similar effect of 100 and 1000 MOI, JNK showed a decrease in
levels and activation at the highest dose (1000 MOI).
Alternately, the MH-S cells were pretreated with p38 and JNK
inhibitors to understand the role of MAPKs based on inhibition.
Interestingly, use of a p38 inhibitor (SB202190) or a JNK inhibitor
(SP600125) 1h prior to challenging with 700506 led up to . 80%
(p#0.0051) decrease in the tested cytokines including IL-1a, IL-
1b, TNF-a, IL-6, and GM- CSF (Fig 8A to E) as well as a
significant inhibition of NO induction (Fig 8F). On the other hand,
the two inhibitors showed a somewhat opposite effect on cellular
damage response (Fig 9A); the effect was further confirmed using
increasing doses of the inhibitors (Fig 9B). Taken together, the
MAPK inhibition (p38 and JNK) abrogated in part the
proinflammatory response suggesting the role of MAPK pathway
in HP immunopathogenesis.
Figure 5. Comparison of M. immunogenum genotypes 700506,
MJY-3, MJY-4, MJY-12 and MJY-14 for induction of cellular
response in terms of LDH release and cell viability loss in MH-S
cells. The cells were infected at a 100 MOI dose for 24h. Values are
presented as means 6 standard deviations calculated based on the
data obtained from three independent experiments; each experiment
was done in triplicate. Asterisk (*) indicates statistically significant
(P#0.05) difference from the Vehicle-treated group and pound sign (#)
indicates statistically significant (P#0.05) difference from the 700506-
treated group.
doi:10.1371/journal.pone.0083172.g005
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Discussion
HP, also known as an extrinsic allergic alveolitis, is primarily an
immune-mediated disorder which is characterized by inflamma-
tion changes in the lung. Alveolar macrophages (AMs) are the first
line of defense against any invading bacterial pathogens in the
exposed lung and are known to mediate both innate and adaptive
immune responses. AMs offer a hostile environment to some
pathogens and a conducive environment for survival/multiplica-
tion to others, the latter including the species of pathogenic
mycobacteria such as M. tuberculosis. However, the fate of M.
immunogenum inside the macrophages per se is not yet known. The
current study being the first attempt to understand the survival
and/or multiplication of this relatively new mycobacterial
pathogen is therefore significant. Based on multiple lines of
evidence (intracellular CFU changes, electron microscopy), our
data show that MI is indeed capable of intracellular survival and
multiplication within alveolar macrophages and shows significant
rate of buildup of pathogen load (2.6-log in 72 hours). Alveolar
macrophages were therefore used as a surrogate to study host
lung-pathogen interactions of M. immunogenum in this study. As the
study involved the use of a range of variables and thus required a
large number of macrophages, the murine AM cell line MH-S was
used. MH-S was chosen because this cell line has been
demonstrated to be morphologically and functionally quite similar
to its parent primary murine AMs [12]. A broad range of
pathogen dose (0.001–1000 MOI) was tested to capture both the
dose levels causing low to high immunological changes as well as
the minimum dose(s) causing cellular damage.
Our results demonstrate that MI is a potent activator of
inflammatory responses in the exposed alveolar macrophages
(MH-S) in culture. MI activated the MH-S cells by inducing
proinflammatory mediators including NO and inflammatory
cytokines in a dose- and time- dependent manner, albeit to a
variable extent. Interestingly, while the entire test dose range
(0.001 – 1000 MOI) induced cellular and/or inflammatory/
immunological responses, only the higher doses (10–1000 MOI)
caused significant (p#0.05) immunological response.
Figure 6. Comparison of M. immunogenum genotypes 700506, MJY-3, MJY-4, MJY-12 and MJY-14 for induction of proinflammatory
mediators (cytokines/NO) in MH-S cells. The cells were infected at a 100 MOI dose for 24h. A & B. Levels of proinflammatory cytokines IL-1a and
IL-1b in both culture supernatant and cell lysate. C, D, & E. Levels of TNF- a, IL-6 and GM-CSF in cell culture supernatant. F. Level of NO measured as
nitrite in cell culture supernatant. Asterisk (*) and pound sign (#) indicate statistically significant (P#0.05) difference from the vehicle-treated and
700506-treated groups, respectively. Values are presented as means 6 standard deviations calculated based on the data obtained from three
independent experiments; each experiment was done in triplicate.
doi:10.1371/journal.pone.0083172.g006
M. immunogenum Interaction with Macrophages
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MI caused an increase in the proinflammatory cytokines TNF-
a, IL-6, IL-1a, and IL-1b in the infected macrophages. The
induction was observed as early as 3h post- infection, and the levels
increased with time through the entire 24h post-infection period.
The induction was dose-dependent, which may be due to a greater
intracellular build up in macrophages of the responsible MI
virulence factor or antigen at higher dose (MOI). Proinflammatory
cytokine elevation in alveolar macrophages on exposure to MWF-
isolated mycobacteria is particularly interesting, considering the
available evidences of increased proinflammatory and decreased
anti-inflammatory cytokines expression in hypersensitivity pneu-
monitis [10,11,15]. Inflammatory cytokines examined in this
study, are known to be immune-regulatory molecules. For
example, a high level of TNF-a is a crucial factor for controlling
primary infection, as it induces the expression of other proin-
flammatory cytokines such as IL-1 and of several chemotactic
cytokines, which attract immune cells to the site of infection
[16,17]. TNF-a in particular, as well as IL-1b and IL-6, are
involved not only in innate immunity but also may regulate
activation of other components of the immune response system,
especially T cells and the macrophages (possibly in an autocrine
manner).
Interestingly, IL-b and IL-1a were detected primarily in cell
lysates, indicating their intracellular localization. Proinflammtory
stimuli induce expression of the IL-1b proform but maturation
and release are controlled by inflammasome that mediates
caspase-1 dependent processing of IL-1b [18]. Caspase-1 and
the inflammasome components are important in the host defense
against pathogenic microorganisms as lack of caspase-1 in knock-
out mice leads to an increased susceptibility to a variety of
infections, such as those with Francisella tularensis [19], Legionella
pneumophila [20], Shigella spp. [21], Salmonella spp. [22,23] and
Pseudomonas aeruginosa [24]. Experimental infections with some of
these pathogens have been also investigated in knock-out mice
lacking components of the inflammasome. In this respect, ASC-
deficient mice have been shown to be more susceptible to
infections with some bacteria (Francisella and Staphylococcus)
[19,25], as well as influenza viruses [26], demonstrating its
importance in host defense mechanisms. In light of these
observations in other pathogenic species of bacteria, MI 700506
might be involved in dysregulation of inflammosome activity in
alveolar macrophages leading to intracellular localization of IL-1b.
Unlike the proinflammatory cytokines, IL-10 was below the
detection limit in the infected MH-S cells. IL-10 is an anti-
inflammatory and immunosuppressive cytokine and an inhibitor of
activated macrophages and, as such, controls innate as well as cell-
mediated immunity. IL-10 blocks the production of proinflamma-
tory cytokines, such as IL-12 and TNF-a, and reduces the
expression of MHC class II molecules, which are required for
antigen presentation [27]. Our data suggest that MI inhibits IL10
expression in macrophages thereby allowing the activation of
macrophages via induction of proinflammatory cytokines. Inability
to control activated inflammatory response leads to lung cellular
influx and neutrophil recruitment, which are a hallmark for HP
pathology [28].
Substantial amount of NO was induced in the MI-infected
macrophages which is a classical sign of inflammatory response.
The NO production increased in a dose- and time- dependent
manner. Proinflammatory cytokines particularly IL-6, TNF-a and
IL-1b, are known to initiate the production of NO [29]. Although
the cytotoxicity due to MI was prominent only with high doses and
extended time of exposure, the initiation of the signaling cascade
Figure 7. Activation of MAPKs in alveolar macrophages on infection with M. immunogenum 700506. A. p38 immunoblot. B. SAPK/JNK
immunoblot. Activation was assessed in terms of upregulation of total MAPK expression levels and increase in phosphorylated MAPK. Densitometric
analysis of the Western blots was done using the NIH’s Image J software. Lanes 1-8 represent vehicle control (VC), 0.001, 0.01, 0.1, 1, 10, 100 and
1000 MOI, respectively. Details on the antibodies for total- and phospho- MAPKs and b-actin are described under the Materials and Methods section.
Values are presented as means 6 standard deviations calculated based on the data obtained from three independent experiments; each experiment
was done in triplicate. Asterisk (*) indicates statistically significant (P#0.05) difference as compared to the vehicle control.
doi:10.1371/journal.pone.0083172.g007
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leading to cell death (apoptosis) maybe expected at the preceding
lower doses in this model.
Mechanistic basis of the observed variable activation potential
of individual genotypes toward macrophages is not yet clear. The
genotypic differences may involve variable regulation of specific
signaling and transcriptional machinery in response to variable
repertoire of antigens or virulence factors in individual MI
genotypes.
Induction of proinflammatory cytokines in response to invading
pathogens may result via activation of different host-cell signaling
cascades and pathways. The p38 and JNK kinases are the
members of the MAPK superfamily which plays important roles in
signal transduction in a wide range of biological processes such as
inflammation, cell survival, and apoptosis [30,31]. We, therefore,
examined the role of JNK and p38 in MI-infected macrophages.
Our data showed that inhibition of either JNK or p38 could
significantly block the cytokine induction (IL-1a, IL-1b, TNFa
and IL-6) in MI-infected macrophages. This seems consistent with
earlier studies on other cell-stimuli interactions [32,33]. Previous
studies have shown that species of mycobacteria trigger MAPK
signaling pathways through engagement of TLRs [34,35,36,37,38]
and that MAPK activation is required for mycobacteria-induced
TNF-a secretion in certain species [34,38] and cell death
[39,40,41]. In this context, our results on dose-dependent
upregulation and/or phosphorylation of both p38 and JNK in
MI-infected macrophages imply the correlation between MAPK
activation and inflammatory response. On the other hand, our
MAPK inhibitor studies demonstrated that p38 and JNK
pathways are necessary for the observed induction of different
cytokines (IL-1a, IL-1b, TNF-a and IL-6) whereas GM-CSF
appeared to be regulated via JNK pathway. These observations
on role of p38 and JNK are in contrast with the observed role of
ERK in cytokine induction by infected macrophages for other
mycobacterial species [38,41]. Our observation on significant
alleviation of the viability loss in the infected cells treated with p38
and JNK inhibitors could possibly be ascribed to concomitant
significant decrease in NO production in inhibitor-treated cells;
this is because lowered NO can directly promote survival/
multiplication of the pathogen in the MH-S cells leading to
enhanced loss of viability. Alternately, there are several recent
reports that also suggest that JNK and p38 MAPK pathways could
play role in cell survival during stress [42,43,44] or infection [45].
In conclusion, our data show that M. immunogenum induces
inflammatory and cytotoxicity responses in alveolar macrophages
Figure 8. Effect of p38 inhibitor (SB202190) and JNK inhibitor (SP600125) on expression of proinflammatory mediators (cytokines/
NO) in MH-S cells infected with M. immunogenum 700506. A & B. Levels of proinflammatory cytokines IL-1a and IL-1b in cell culture
supernatant and lysate. C, D, & E. Levels of TNF-a, IL-6, and GM-CSF in cell culture supernatant. F. Levels of NO production (measured as nitrite). Values
are presented as means 6 standard deviations calculated based on the data obtained from three independent experiments; each experiment was
done in triplicate. Asterisk (*) and pound sign (#) indicate statistically significant (P#0.05) difference from the vehicle control and 700506 (no
inhibitor) control, respectively.
doi:10.1371/journal.pone.0083172.g008
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in a dose- and time-dependent manner. Two of its genotypes,
700506 and MJY-3, cause greater proinflammatory changes as
compared to the other known genotypes (MJY-4, MJY-12 and
MJY-14). Variable induction of proinflammatory cytokines may
account in part for the differential HP-inducing potential of these
MI genotypes. To gain a better understanding of the antigenic
proteins or virulence factors involved in the activation of alveolar
macrophages, genetic disruption of bacterial factors might be
useful. The results further show that the inflammatory responses
are primarily mediated via p38 and JNK suggesting the role of
MAPK pathway in MI-caused HP immunopathogenesis. Follow-
up studies in this direction will elucidate further mechanisms by
which M. immunogenum is able to regulate/activate MAPK and
other host-signaling pathways for establishing HP pathology. The
current study on the interactions between M. immunogenum and host
lung macrophages is a significant initial step in the direction of our
emerging understanding of the immunopathogenesis mechanisms
of occupational HP in machinists.
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